This study of pregnant women with confirmed COVID-19 infection in England aims to answer important questions about the impact of COVID-19 on pregnant women and their infants, and to better understand the risk and routes of transmission from mother to baby.
Primary objective: To assess the risk of COVID-19 infection in newborn infants born to pregnant women with confirmed COVID-19 infection and determine possible routes of mother-to-child transmission
Type of study: Observational
Countries: United Kingdom
Sample size: As many pregnant women in England over 12 months as possible
Study participants: Confirmed COVID-19 infection in pregnant women ≥ 24 weeks gestation
Study status: Recruiting
- Dr Shamez Ladhani, Public Health England
Last updated: August 2020
Note that study-related documents posted on the COVID-19 Clinical Research Coalition (COVID-19 CRC) website have been shared by coalition members for information. Some may have been approved by Ethics Review Boards and others may still be in draft form. Documents posted here may have been further amended before being used in the conduct of the respective trials they were designed for. It is recommended that users review these documents carefully and, if they plan to use them, adapt them appropriately for their intended use. The COVID-19 CRC and its members cannot accept any liability for any claim, loss or damages as a result of any reliance placed on, or use of, these documents.